• 1. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Recent Advances in the Study of 4-(Piperidine-3-carbonyl)morpholine (CAS: 35090-96-1)

4-(Piperidine-3-carbonyl)morpholine (CAS: 35090-96-1) is a compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have explored its potential as a versatile scaffold in drug discovery, particularly due to its unique structural features that enable interactions with various biological targets. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and potential therapeutic applications.

A 2023 study published in the Journal of Medicinal Chemistry highlighted the efficient synthesis of 4-(piperidine-3-carbonyl)morpholine derivatives via a novel multicomponent reaction. The researchers optimized the reaction conditions to achieve high yields (up to 85%) and excellent purity, making it a viable candidate for large-scale production. The study also demonstrated the compound's stability under physiological conditions, a critical factor for its potential use in drug development.

In terms of biological activity, recent in vitro studies have shown that 4-(piperidine-3-carbonyl)morpholine exhibits promising inhibitory effects on specific kinase enzymes implicated in cancer and inflammatory diseases. For instance, a 2024 preprint from BioRxiv reported that the compound selectively inhibits the PI3K/AKT/mTOR pathway, a key signaling cascade in tumorigenesis. These findings suggest its potential as a lead compound for developing targeted cancer therapies.

Further investigations into the compound's pharmacokinetic properties have revealed favorable absorption and distribution profiles. A 2023 study in Drug Metabolism and Disposition utilized advanced LC-MS techniques to characterize the compound's metabolic stability and plasma protein binding. The results indicated moderate clearance rates and high bioavailability, supporting its suitability for oral administration in preclinical models.

Despite these advancements, challenges remain in optimizing the selectivity and potency of 4-(piperidine-3-carbonyl)morpholine derivatives. Ongoing research aims to address these limitations through structure-activity relationship (SAR) studies and computational modeling. For example, a recent collaboration between academic and industrial researchers has employed molecular docking simulations to identify key modifications that enhance target binding affinity while minimizing off-target effects.

In conclusion, 4-(piperidine-3-carbonyl)morpholine (CAS: 35090-96-1) represents a promising scaffold in medicinal chemistry, with recent studies underscoring its synthetic accessibility, biological relevance, and therapeutic potential. Future research directions may include in vivo efficacy studies and the exploration of its applications in other disease areas, such as neurodegenerative disorders and infectious diseases.

• 13146-39-9(2,2-dimethyl-1-(morpholin-4-yl)pentan-1-one)
• 32905-66-1(2,2,4,4-tetramethyl-1-(morpholin-4-yl)pentan-1-one)
• 13146-43-5(1-Hexanone,2-ethyl-2-methyl-1-(4-morpholinyl)-)
• 88321-32-8(Morpholine, 4,4'-[2,2-bis(3-aminopropyl)-1,3-dioxo-1,3-propanediyl]bis-)
• 802255-22-7(Methanone,(1-ethyl-3-piperidinyl)-4-morpholinyl-)
• 63214-57-3(4-(piperidine-4-carbonyl)morpholine)
• 2653-58-9(1-Pentanone,1-(4-morpholinyl)-2-propyl-)
• 1134606-68-0(4-Methyl-4-(N-morpholinylcarbonyl) Piperidine Hydrochloride)
• 79868-48-7(2-ethyl-1-(morpholin-4-yl)hexan-1-one)
• 94467-73-9(4-(piperidine-4-carbonyl)morpholine hydrochloride)